On-line high-performance liquid chromatography method for analyte quantitation from pressurized metered dose inhalers

Journal of Chromatography A

Volumn 1033, Issue 1, 2004, Pages 101-106

  Gupta, Abhishek ^a   Myrdal, Paul B ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Aerosols; Beclomethasone dipropionate; Corticosteroids; Metered dose inhalers; Tetrafluoroethane

Indexed keywords

CONCENTRATION (PROCESS); DRUG THERAPY; ETHANOL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ORGANIC SOLVENTS; PHASE COMPOSITION; PRESSURIZATION; SOLUBILITY;

METERED DOSE INHALER (MDI);

PHASE SEPARATION;

ACETONITRILE; ALCOHOL DERIVATIVE; BECLOMETASONE DIPROPIONATE; CORTICOSTEROID; CORTICOSTEROID DERIVATIVE; SOLVENT; WATER;

ACCURACY; ANALYTICAL EQUIPMENT; ARTICLE; ASTHMA; CHEMICAL COMPOSITION; CONCENTRATION (PARAMETERS); DILUTION; FLOW INJECTION ANALYSIS; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METERED DOSE INHALER; MISCIBILITY; ONLINE ANALYSIS; PHASE SEPARATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; METERED DOSE INHALERS; PRESSURE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

PARNASSIUS APOLLO;

EID: 1542268941     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2004.01.034     Document Type: Article

References (22)

1. Vital and Health Statistics, Table 62, vol. 10, Suppl. 193, December 1993.
2. Survillance for Asthma-United States 1960-1995, Morbidity and Mortality Weekly Report, vol. 47, 24 April 1998, p. SS-1.
3. HHS Targets Efforts on Asthma, US Department of Health and Human Services, 21 May 1998.
4. Williams R.O., Liu J. Eur. J. Pharm. Biopharm. 47:1999;145.
5. Blondino F.E., Byron P.R. J. Pharm. Biomed. 13(2):1999;111.
6. Simms P.J., Towne R.W., Gross C.S., Miller R.E. J. Pharm. Biomed. 17:1998;841.
7. Sethi S.K., Norwood D.L., Haywood P.A., Prime D.J. Biopharm. Sci. 3:1992;63.
8. Norwood D.L., Prime D., Downey B.P., Creasey L., Sethi J.S.K., Haywood P.J. J. Pharm. Biomed. 13:1995;293.
9. R.N. Dalby, A.J. Hickey, S.L. Tiano, in: A.J. Hickey (Ed.), Inhalation Aerosols Physical and Biological Basis for Therapy, Marcel Dekker, New York, 1996.
10. M.E. Whitham, A.M. Eagle, in: P.R. Byron, R.N. Dalby, S.J. Farr (Eds.), Proceedings of the Respiratory Drug Delivery IV, Interpharm Press, Buffalo Grove, IL, 1994, p. 203.
11. P.R. Byron, in: P.R. Byron (Ed.), Respiratory Drug Delivery, CRC Press, Boca Raton, FL, 1990, p. 167.
12. Kirk W.F. J. Pharm. Sci. 61:1972;262.
13. Davies G., Thomas P., Broder I.et al. Ann. Int. Med. 86:1977;549.
14. Toogood J.H., Lefcoe N.M., Haines D.S.M.et al. J. Allergy Clin. Immunol. 62:1978;72.
15. Toogood J.H., Lefcoe N.M., Haines D.S.M.et al. J. Allergy Clin. Immunol. 59:1977;298.
16. Williams M.H. Ann. Int. Med. 95:1981;464.
17. Smith M.J., Hoodson M.E. Lancet. 1:1983;265.
18. LeBelle M., Pike R.K., Graham S.J., Ormsby E.D., Bogard H.A. J. Pharm. Biomed. 14:1996;793.
19. Gupta A., Stein S.W., Myrdal P.B. J. Aerosol Med. 16:2003;167.
20. US Food and Drugs Administration (FDA), Guidance for Industry, Analytical Procedures and Methods Validation, August 2000.
21. ICH Q2B: Validation of Analytical Procedures: Methodology, May 1997.
22. Physical Tests and Determinations, 〈6 2 1〉 chromatography, in: Proceedings of The United States Pharmacopoeia XXII, The United States Pharmacopoeial Convention, Rockville, MD, 1989, p. 1558.